Michielsen P P, Duysburgh I K, Francque S M, Van der Planken M, Van Marck E A, Pelckmans P A
Division of Gastroenterology, University Hospital Antwerp, Belgium.
Acta Gastroenterol Belg. 1998 Apr-Jun;61(2):158-63.
Despite recent advances in diagnostic imaging of the liver, the management of a patient with focal liver lesions often depends on obtaining tissue for histological diagnosis. Ultrasound guided fine needle biopsy is recommended as a safe and reliable method for cyto-histological confirmation of suspected hepatic malignancy. A fine needle is conventionally defined as having an outer diameter < or = 0.9 mm or > or = 19 G. Ultrasound guided fine needle aspiration cytology is found reliable for diagnosing malignancy. Limitations of this method are inadequate sampling and limited value in diagnosis of well-differentiated malignant tumours and benign tumours. Ultrasound guided fine needle cutting biopsy allows to obtain tissue for histological examination according to the Menghini technique. Both methods have high sensitivity, specificity and accuracy in detecting malignancy. In a personal series of 50 fine needle aspiration cytologies, a sensitivity for malignancy of 87% was obtained, with a specificity of 100%. The insufficient sampling rate, however, was 10%. Ultrasound guided fine needle trucut biopsy combines the advantages of a fine needle and a better sampling quality; a lower insufficient sampling rate can be expected without increase in complication rate. Despite the availability of numerous manually operated or (semi-) automated devices, little data have been published up to now on liver lesions. In our hands, it has proven to be a safe and reliable method, with low insufficient sampling rate, allowing correct identification of primary liver malignancies, correct suggestion of the primary source of the majority of metastases and correct identification of most benign liver lesions. Therefore it is considered as the method of choice when focal noncystic liver lesions are to be biopsied.
尽管肝脏诊断成像技术最近取得了进展,但对于患有局灶性肝病变的患者的管理通常仍依赖于获取组织进行组织学诊断。超声引导下细针穿刺活检被推荐为一种安全可靠的方法,用于对疑似肝恶性肿瘤进行细胞组织学确诊。细针通常定义为外径≤0.9毫米或≥19G。超声引导下细针穿刺抽吸细胞学检查被认为对诊断恶性肿瘤可靠。该方法的局限性在于取样不足以及对高分化恶性肿瘤和良性肿瘤诊断价值有限。超声引导下细针切割活检可根据门基尼技术获取组织进行组织学检查。两种方法在检测恶性肿瘤方面都具有高敏感性、特异性和准确性。在个人的50例细针穿刺抽吸细胞学检查系列中,恶性肿瘤的敏感性为87%,特异性为100%。然而,取样不足率为10%。超声引导下细针切割活检结合了细针的优点和更好的取样质量;预计取样不足率会更低,且并发症发生率不会增加。尽管有许多手动操作或(半)自动设备可供使用,但到目前为止,关于肝脏病变的相关数据报道较少。在我们的实践中,它已被证明是一种安全可靠的方法,取样不足率低,能够正确识别原发性肝恶性肿瘤,正确提示大多数转移瘤的原发来源,并正确识别大多数良性肝病变。因此,当要对局灶性非囊性肝病变进行活检时,它被视为首选方法。